Gintaras Zaleskis

Vilnius, VL, Lithuania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Retzius-sparing Retroperitoneal Laparoscopic Radical Prostatectomy (RSR-LRP): A Novel Technique With Favorable Functional and Oncological Outcomes - A Single-surgeon Experience of 186 Consecutive Cases.

Retzius-sparing Retroperitoneal Laparoscopic Radical Prostatectomy (RSR-LRP): A Novel Technique With Favorable Functional and Oncological Outcomes - A Single-surgeon Experience of 186 Consecutive Cases.

Journal: In vivo (Athens, Greece)

Published: January 26, 2026

Clinical Rationale of Dual-Parameter Tumor Markers Reporting Without Reliance on Normal Reference Ranges.

Clinical Rationale of Dual-Parameter Tumor Markers Reporting Without Reliance on Normal Reference Ranges.

Journal: Journal of clinical laboratory analysis

Published: December 12, 2025

Prognostic significance of soluble PD-L1 in prostate cancer.

Prognostic significance of soluble PD-L1 in prostate cancer.

Journal: Frontiers in immunology

Published: March 14, 2024

Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer.

Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer.

Journal: Anticancer research

Published: December 29, 2022

Letter to the Editor Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19-9 and the surgical margin in extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg. 2022; 6:307-315.

Letter to the Editor Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19-9 and the surgical margin in extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg. 2022; 6:307-315.

Journal: Annals of gastroenterological surgery

Published: September 28, 2022

Re: Sylvia H.J. Jochems, Josef Fritz, Christel Häggström, Bengt Järvholm, Pär Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033.

Re: Sylvia H.J. Jochems, Josef Fritz, Christel Häggström, Bengt Järvholm, Pär Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033.

Journal: European urology

Published: June 14, 2022

Thymus Subset Alterations Accompanying Concomitant Tumor Immunity Mimics Phenotypic Patterns of Cytotoxic Drug Doxorubicin.

Thymus Subset Alterations Accompanying Concomitant Tumor Immunity Mimics Phenotypic Patterns of Cytotoxic Drug Doxorubicin.

Journal: In vivo (Athens, Greece)

Published: January 31, 2022

Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?

Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?

Journal: Journal for immunotherapy of cancer

Published: August 09, 2021

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients.

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients.

Journal: Journal of clinical medicine

Published: July 11, 2021

Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure.

Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure.

Journal: Anticancer research

Published: March 28, 2021

A Refinement of Clinical Tumor Marker Monitoring: Why Not Use an Inverse Value of Doubling Time?

A Refinement of Clinical Tumor Marker Monitoring: Why Not Use an Inverse Value of Doubling Time?

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Published: October 10, 2020

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?

Journal: Journal of translational medicine

Published: July 22, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026